Patients with MBC can survive longer without metastatic symptoms when treated with these systemic therapies. However, MBC cannot be cured with ICI or other treatments and the majority of MBC patients will die of their disease. It is important to use all available treatments to obtain maximal control of symptoms, prevent serious complications, and prolong life with minimal disruption of daily activities and quality of life. We endeavor to use fewer powerful drugs, such as hormone therapy and oral agents, and thereby minimize severe adverse events.
Loco-regional therapy for isolated locoregional lymph node recurrence of breast cancer: focusing on surgical treatment with combined therapy
Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer
Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
The series “Loco-regional Therapy for Metastatic Breast Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Tadahiko Shien and Kaori Terata served as the unpaid Guest Editors for the series.